Skip to main content
Anixa Biosciences Inc logo

Anixa Biosciences Inc — Investor Relations & Filings

Ticker · ANIX ISIN · US45069V2034 LEI · 549300PW2C2QTAJL2D19 US Professional, scientific and technical activities
Open in API
Filings indexed 958 across all filing types
Latest filing 2017-04-04 Director's Dealing
Country US United States of America
Listing US ANIX

About Anixa Biosciences Inc

https://www.anixa.com/

Anixa Biosciences Inc. is a clinical-stage biotechnology company focused on developing therapies and vaccines for the treatment and prevention of cancer. The company's portfolio is centered on two main platforms: a therapeutics program and a vaccine program. The therapeutics portfolio features a Chimeric Antigen Receptor T-cell (CAR-T) immunotherapy, which genetically engineers a patient's own immune cells to target and destroy solid tumors. The vaccine portfolio includes preventative and therapeutic candidates for various cancers, with a primary focus on breast and ovarian cancer, and discovery programs for lung, colon, and prostate cancer. Anixa aims to address critical unmet needs in oncology through these innovative approaches.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2017-04-04 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The text specifically mentions the closing of a rights offering and the issuance of new shares, which is a capital raising event. The document includes a press release about the rights offering and does not contain detailed financial statements or comprehensive financial analysis. The length is 3188 characters, which is relatively short and consistent with a current report rather than a full financial report. Therefore, this filing is best classified as a Capital/Financing Update (CAP).
2017-04-04 English
Regulatory Filings 2017
Regulatory Filings Classification · 70% confidence The document text appears to be an encoded or binary file content (likely a PDF or similar) rather than readable text. There are no clear keywords, regulatory references, form names, fiscal period dates, or document titles visible in the provided text. The length is 15,000 characters, which is substantial, but without readable content or metadata indicating the nature of the document, it is impossible to classify it as a specific report type. Given the lack of identifiable information and the fallback rule, the document should be classified as a Regulatory Filing (RNS).
2017-04-03 English
FORM S-3
Capital/Financing Update Classification · 95% confidence The document is a Form S-3 Registration Statement filed with the SEC, which is used for registering securities for sale to the public. It includes details about the securities being registered, the offering, selling stockholders, risk factors, and other related information. This is a capital markets filing related to fundraising and securities registration, not a financial report, earnings release, or management discussion. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed offering information, consistent with a registration statement.
2017-03-31 English
REQUEST WITHDRAWAL OF S-1 FILE NO. 333-215799
Regulatory Filings Classification · 100% confidence The document is a formal letter addressed to the SEC requesting the withdrawal of a previously filed Registration Statement on Form S-1. It references Rule 477 under the Securities Act of 1933 and explicitly states the withdrawal of the Registration Statement. There is no financial data, report content, or presentation material included. The document is short (1319 characters) and serves as an official notice to the SEC rather than a financial report or detailed filing. This fits the category of a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2017-03-24 English
FORM 10-Q
Interim / Quarterly Report Q1 2017
2017-03-15 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.